The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels.

Because of the relevance for HER2 for therapeutic strategies, the correct determination of this marker in the pathology laboratory has been in the focus of clinical discussions for many years.

PARIS--(BUSINESS WIRE)--Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the ...

John E. Tomaszewski is a pathologist. He is an expert on clinical laboratory testing and the use of clinical laboratory data for helping patients and clinicians plan treatment decisions. Tomaszewski’s ...

The American Society for Clinical Pathology (ASCP) is the first and only national medical organization to call on the federal government to immediately develop and implement a widespread COVID-19 ...

Anyone who has endured a COVID-19 test and then counted down the hours until the results arrived knows how important it is to the patient to shrink the wait, and reduce anxiety and time in ...

Laboratory tests play a critical part of the healthcare system. Ordering and billing for these tests, however, is not always cut-and-dry. Compliance with federal laws and rules (like the Clinical ...

In a recent study published in Nature Communications, researchers establish AnimalGAN as a reliable alternative for generating synthetic pathology data in an effort to ultimately reduce animal testing ...

Congratulations to Marisa Marques, M.D., Professor, Laboratory Medicine, who has accepted a nomination to join the American Board of Pathology (ABPath) Test Development and Advisory Committee for ...